Why is Godavari Drugs falling/rising?

As of 07-Aug, Godavari Drugs Ltd is currently priced at Rs 83.75, reflecting an increase of Rs 1.84 or 2.25%. The stock has shown a trend reversal, gaining after two consecutive days of decline, and it outperformed its sector by 1.6% today. Despite this positive movement, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend over a longer period. Additionally, the delivery volume has significantly decreased by 84.33% compared to the 5-day average, suggesting a decline in investor participation. Over the past month, the stock has decreased by 6.94%, while its year-to-date performance shows a decline of 23.41%. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the stock's recent movement.
In the broader market context, Godavari Drugs has underperformed compared to the Sensex, which has seen a decline of 3.38% over the past month, while Godavari's decline is more pronounced. However, in the short term, the stock's performance today contrasts with the Sensex's 0.69% decline over the past week, indicating a temporary rebound despite the overall negative trend. The stock's long-term performance shows a gain of 24.81% over the last three years, which is less than the Sensex's 38.08% increase, and a substantial 118.10% rise over five years, slightly outperforming the benchmark's 111.94%. This suggests that while the stock is experiencing short-term volatility, it has had a strong historical performance relative to the market.